<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="rss.xsl"?>
<rss version="2.0">
  <channel>
          <title>Endometrial Cancer - livepress.com</title>
      <link>http://Endometrial Cancer.livepress.com</link>
        <description>Updated every 15 minutes of every day - FOR PERSONAL USE ONLY</description>
    <language>en</language>
    <lastBuildDate/>
    <copyright>Copyright: (C) livepress.com</copyright>
    <docs/>
    <image>
      <title>livepress.com</title>
      <url>http://livepress.com/img/logo-live-press.gif</url>
      <link>http://livepress.com</link>
    </image>

    <item>
      <title><![CDATA[Insulin resistance linked to endometrial cancer 
    (Reuters)
]]></title>
      <link>http://livepress.com/go/?114602</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?114602</guid>
      <pubDate>2006-06-28 13:29:45</pubDate>
      	<description><![CDATA[Reuters - Resistance to the effects of 
the blood-sugar regulating hormone insulin could boost a 
woman's risk of  endometrial cancer , a new study suggests.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_114604.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
    <item>
      <title><![CDATA[Study Confirms Tamoxifen Raises Endometrial Cancer Risk 
    (HealthDay)
]]></title>
      <link>http://livepress.com/go/?40760</link>
      <source>YAHOO</source>
      <guid isPermaLink="false">http://livepress.com/go/?40760</guid>
      <pubDate>2006-03-02 16:48:01</pubDate>
      	<description><![CDATA[HealthDay - WEDNESDAY, March 2 (HealthDay News) -- Doctors often prescribe the drug tamoxifen to  breast cancer  patients over the long term, to help reduce the chances of cancer recurrence.]]></description>
            	<enclosure url="http://livepress.com/images/top-stories_114587.jpg"
                   type="image/jpg"
		   length="0"/>
          </item>
  </channel>
</rss>